Literature DB >> 3265656

The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.

U Sundin1, Z Heigl, K G Sundqvist.   

Abstract

The antibody reactivity to liver specific protein (LSP) and a crude liver antigen of sera from patients with chronic active hepatitis (CAH) were studied along with other related diseases and healthy individuals. CAH sera containing liver reacting antibodies were selected using an ELISA with a crude liver preparation as antigen and subsequently the specificity was analysed by immunoblotting of SDS-PAGE-separated LSP. The incidence of IgG antibodies to the crude liver antigen and LSP in sera from 15 patients with CAH was 94% and 55% respectively. In the healthy control group (n = 30) the corresponding figures were 3% and 17%. Sera from patients with other autoimmune conditions with considerable reactivity in the crude liver ELISA test were those with antibodies against extractable nuclear antigens (ENA) and thyroid gland antigens, while the anti-nuclear antibody (ANA) group as a whole did not differ from the control group. In immunoblotting of SDS-PAGE-separated crude liver and LSP antigens, the IgG binding pattern of ELISA IgG positive CAH sera and sera from patients with thyroid disease was distinct, with bands corresponding to antigens of molecular weights of 38, 45 and 50 kD which were not observed in ELISA negative CAH sera or in sera from patients with other diseases and among healthy controls.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265656      PMCID: PMC1541812     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2".

Authors:  U J Behrens; F Paronetto
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  How specific is liver-specific protein?

Authors:  C Feighery; D G Weir
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

4.  Demonstration of organ-nonspecific antigens in liver-specific protein.

Authors:  K Riisom; H Diederichsen
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

5.  Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M McFarlane; G N Major; P Tolley; R Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

6.  Acute viral hepatitis, types A, B and non-A, non-B: a prospective study of the epidemiological, laboratory and prognostic aspects in 280 consecutive cases.

Authors:  O Weiland; J V Berg; B Flehmig; G Lindh; P Lundbergh
Journal:  Scand J Infect Dis       Date:  1981

7.  Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity.

Authors:  M Manns; K H Meyer zum Büschenfelde; G Hess
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

8.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

9.  Development of a micro enzyme-linked immunosorbent assay for antibodies against liver-specific membrane lipoprotein.

Authors:  I G McFarlane; P Tolley; G Major; B M McFarlane; R Williams
Journal:  J Immunol Methods       Date:  1983-11-11       Impact factor: 2.303

10.  Hepatic disorders associated with liver-kidney microsomal antibodies.

Authors:  M G Smith; R Williams; G Walker; M Rizzetto; D Doniach
Journal:  Br Med J       Date:  1974-04-13
View more
  1 in total

1.  Plasma membrane association of primary biliary cirrhosis mitochondrial marker antigen M2.

Authors:  U Sundin; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.